Dr. Angelika Batorova

March 1, 2024

Challenges associated with access to recently developed hemophilia treatments in routine care – healthcare professionals’ perspectives.

Authors

Berger K, O’Rourke RH, Matteo Nicola DD, Batorova A, Kavakli K, Mannuccio PM, Wolfgang Schramm W, Rhonda BL, Aledort L on behalf of the International Prophylaxis Study Group.

Citation

Hematologica. 2024 Mar 1; 110(3):673-682. DOI: 10.3324/haematol.2024.285647

September 19, 2022

Are all licensed hemostatic agents for hemophilia therapy accessible to patients? Letter to the Editor

Authors

Berger K, Batorova A, Bohn RL, di Minno M, Mannucci P, Kavakli K, Schramm W, Aledort L on behalf of the International Prophylaxis Study Group

Citation

Haemophilia. 2022; 28:e256–e258. DOI: 10.1111/hae.14660